New FFA1 agonist derived from an old scaffold shows potential for treatment of type 2 diabetes Nov. 21, 2019
Phase I trial studies Rocket's hematopoietic cell-based gene therapy for pyruvate kinase deficiency Nov. 18, 2019
RSS